Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Sega, Emanuela I ^a   Leveson Gower, Dennis B ^a   Florek, Mareike ^a   Schneidawind, Dominik ^a   Luong, Richard H ^b   Negrin, Robert S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GRANZYME B; INTERFERON; INTERLEUKIN 10; KI 67 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; GENE; GENE FUNCTION; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LAG 3 GENE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TROGOCYTOSIS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; FLOW CYTOMETRY; FLUORESCEINS; GRAFT VS HOST DISEASE; LUMINESCENT MEASUREMENTS; MICE; MICE, KNOCKOUT; SUCCINIMIDES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84899921390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086551     Document Type: Article

References (43)

1. Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373: 1550-1561.
2. Reddy P, Ferrara JLM (2008) Mouse models of graft-versus-host disease. StemBook. Cambridge (MA).
3. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature medicine 9: 1144-1150. (Pubitemid 37173698)
4. Nguyen VH, Zeiser R, Dasilva DL, Chang DS, Beilhack A, et al. (2007) In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109: 2649-2656. (Pubitemid 46425916)
5. Colonna L, Sega EI, Negrin RS (2011) Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 17: S58-62.
6. Leveson-Gower DB, Olson JA, Sega EI, Luong RH, Baker J, et al. (2011) Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Blood 117: 3220-3229.
7. Cohen JL, Boyer O (2006) The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease. Current opinion in immunology 18: 580-585. (Pubitemid 44322035)
8. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Narula SK, Smith SR, et al. (1998) Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease. Transplantation 66: 1220-1229. (Pubitemid 28530328)
9. Banovic T, MacDonald KP, Morris ES, Rowe V, Kuns R, et al. (2005) TGFbeta in allogeneic stem cell transplantation: friend or foe? Blood 106: 2206-2214. (Pubitemid 41291742)
10. Gorelik L, Flavell RA (2000) Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
11. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. The Journal of experimental medicine 196: 389-399. (Pubitemid 34875667)
12. Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499. (Pubitemid 34534513)
13. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, et al. (1990) LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171: 1393-1405. (Pubitemid 20167538)
14. Workman CJ, Vignali DA (2003) The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 33: 970-979. (Pubitemid 36546685)
15. Huard B, Tournier M, Hercend T, Triebel F, Faure F (1994) Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol 24: 3216-3221.
16. Huard B, Gaulard P, Faure F, Hercend T, Triebel F (1994) Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 39: 213-217. (Pubitemid 24014846)
17. Kisielow M, Kisielow J, Capoferri-Sollami G, Karjalainen K (2005) Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells. European journal of immunology 35: 2081-2088. (Pubitemid 41015047)
18. Workman CJ, Wang Y, El Kasmi KC, Pardoll DM, Murray PJ, et al. (2009) LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol 182: 1885-1891.
19. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, et al. (2004) Role of LAG-3 in regulatory T cells. Immunity 21: 503-513. (Pubitemid 39370506)
20. Huard B, Prigent P, Tournier M, Bruniquel D, Triebel F (1995) CD4/major histocompatibility complex class II interaction analyzed with CD42 and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur J Immunol 25: 2718-2721.
21. Workman CJ, Cauley LS, Kim IJ, Blackman MA, Woodland DL, et al. (2004) Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J Immunol 172: 5450-5455. (Pubitemid 38542045)
22. Grosso JF, Kelleher CC, Harris TJ, Maris CH, Hipkiss EL, et al. (2007) LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 117: 3383-3392. (Pubitemid 350096994)
23. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37.
24. Lucas CL, Workman CJ, Beyaz S, LoCascio S, Zhao G, et al. (2011) LAG-3, TGF-beta, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood 117: 5532-5540.
25. Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, et al. (2005) In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106: 1113-1122. (Pubitemid 41076462)
26. Chang CH, Hong SC, Hughes CC, Janeway CA, Jr., Flavell RA (1995) CIITA activates the expression of MHC class II genes in mouse T cells. International immunology 7: 1515-1518.
27. Davis DM (2007) Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nature reviews Immunology 7: 238-243.
28. Blazar BR, Carreno BM, Panoskaltsis-Mortari A, Carter L, Iwai Y, et al. (2003) Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. Journal of immunology 171: 1272-1277. (Pubitemid 36900057)
29. Veenstra RG, Taylor PA, Zhou Q, Panoskaltsis-Mortari A, Hirashima M, et al. (2012) Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells. Blood 120: 682-690.
30. Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, et al. (2011) Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. Journal of immunology 187: 3493-3498.
31. Li N, Wang Y, Forbes K, Vignali KM, Heale BS, et al. (2007) Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J 26: 494-504. (Pubitemid 46160949)
32. Andreae S, Buisson S, Triebel F (2003) MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102: 2130-2137. (Pubitemid 37122390)
33. Buisson S, Triebel F (2005) LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors. Immunology 114: 369-374. (Pubitemid 40314809)
34. Okamura T, Fujio K, Shibuya M, Sumitomo S, Shoda H, et al. (2009) CD4+CD252LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proceedings of the National Academy of Sciences of the United States of America 106: 13974-13979.
35. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, et al. (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
36. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
37. Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immunosup-pression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. The Journal of experimental medicine 194: 629-644. (Pubitemid 32844773)
38. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25 - naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of experimental medicine 198: 1875-1886. (Pubitemid 38032120)
39. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, et al. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601. (Pubitemid 39370513)
40. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ (2005) Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. Journal of immunology 174: 1783-1786. (Pubitemid 40223916)
41. Yamaguchi T, Wing JB, Sakaguchi S (2011) Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Seminars in immunology 23: 424-430.
42. Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends in molecular medicine 13: 108-116. (Pubitemid 46341958)
43. Zhou G, Ding ZC, Fu J, Levitsky HI (2011) Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response. Journal of immunology 186: 2148-2155.